Percussionaire, Inc., REF: P5-TEE, Qty: 1, Rx Only. IPV (Intrapulmonary Percussive Ventilation) ...
FDA Device Recall #Z-3207-2024 — Class I — August 21, 2024
Recall Summary
| Recall Number | Z-3207-2024 |
| Classification | Class I — Serious risk |
| Date Initiated | August 21, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Percussionaire Corporation |
| Location | Sandpoint, ID |
| Product Type | Devices |
| Quantity | 50,460 units |
Product Description
Percussionaire, Inc., REF: P5-TEE, Qty: 1, Rx Only. IPV (Intrapulmonary Percussive Ventilation) therapy In-Line Valve
Reason for Recall
Updated labeling to ensure that blue cap on in-line valve is removed, prior to delivery of (Intrapulmonary percussive ventilation) IPV therapy.
Distribution Pattern
US: Nationwide OUS: Israel Japan Russia Switzerland Canada Turkey
Lot / Code Information
No UDI/ Lots: 240620, 240610, 240418, 240326, 230612, WO07066, WO07010, WO06020, WO05019, WO04884, WO04827, WO04756, WO04714, WO04656, WO04625, WO04596, WO04553, WO04398, WO04356, WO04061, WO03846, WO03748, WO03688
Other Recalls from Percussionaire Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0031-2026 | Class I | Phasitron 5, IPV In-Line Valve, (Intrapulmonary... | Sep 17, 2025 |
| Z-0960-2025 | Class I | VDR4 Phasitron Breathing Circuit Models that co... | Dec 23, 2024 |
| Z-0208-2025 | Class I | Phasitron5 Breathing Circuit (P5-10, P5-HC, P5-... | Sep 16, 2024 |
| Z-3208-2024 | Class I | Percussionaire, Inc., REF: P5-TEE-20, Qty: 20,... | Aug 21, 2024 |
| Z-0637-2024 | Class I | High Frequency Transport Phasitron Breathing Ci... | Dec 12, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.